Endocrine Society GUIDELINES Bundle (free trial)

Hirsutism

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140154

Contents of this Issue

Navigation

Page 4 of 9

Figure 2. Evaluation and Treatment of Hirsutism in Premenopausal Women Initial evaluation of complaint of hirsutism Normal variant Abnormal hirsutism score or local sexual hair growth with clinical evidence of hyperandrogenic endocrine disorder* Local hair growth, isolated Drug or medicine use Trial of dermatologic therapy Total testosterone blood level by specialty assay Course stable or improving Hair growth progresses Discontinue if possible Testosterone normal Testosterone elevated Hirsutism moderate-severe and/or other clinical evidence of hyperandrogenic endocrine disorder* Free testoserone blood level (calculated from total testosterone and sex hormone- binding globulin [SHBG] or equilibrium dialysis) Free testosterone normal Free testosterone elevated Re-evaluate if hirsutism progresses Trial of dermatologic or oral contraceptive (OC) therapy Course stable or improving Hair growth progresses Idiopathic hirsutism Hirsutism mild and isolated Androgen excess laboratory work-up* Hyperandrogenemia * Major hyperandrogenic endocrine disorders to consider: • Polycystic ovary syndrome • Nonclassic congenital adrenal hyperplasia • Cushing's syndrome • Virilizing tumor • Hyperprolactinemia

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Hirsutism